`
`
`
`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`
`
`
`MEDTRONIC, INC., AND MEDTRONIC VASCULAR, INC.
`Petitioners,
`
`v.
`
`TELEFLEX INNOVATIONS S.A.R.L.
`Patent Owner.
`
`
`
`
`Case IPR2020-00133
`Patent RE45,760
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`MANDATORY NOTICES OF
`PATENT OWNER TELEFLEX MEDICAL DEVICES S.A.R.L.
`PURSUANT TO 37 C.F.R. § 42.8
`
`
`
`
`Pursuant to 37 C.F.R. § 42.8, Patent Owner, Teleflex Medical Devices
`
`S.A.R.L.1 (“Teleflex”), submits the following mandatory notice information:
`
`1. Real Party-In-Interest
`
`Teleflex Medical Devices S.A.R.L. is the real party-in-interest. Teleflex
`
`
`
`
`Innovations S.A.R.L. merged into Teleflex Medical Devices S.A.R.L. Teleflex
`
`also identifies the following additional real parties in interest: Vascular Solutions
`
`LLC, Arrow International, Inc., and Teleflex LLC. Teleflex Incorporated is the
`
`ultimate parent of the entities listed above.
`
`2. Related Matters
`
`Patent RE45,760 (“’760 patent”) is the subject of litigation in two separate
`
`
`
`
`actions in the U.S. District Court for the District of Minnesota: Vascular Solutions
`
`LLC, et al. v. Medtronic, Inc., et al., No. 19-cv-01760 (D. Minn., filed July 2,
`
`2019); and (ii) QXMedical, LLC v. Vascular Solutions, LLC, No. 17-cv-01969 (D.
`
`Minn., filed June 8, 2017).
`
`
`
`The ’760 patent is a reissue of U.S. Pat. No. 8,292,850 (“the ʼ850 patent).
`
`The ʼ850 patent was previously at issue (i) in the U.S. District Court for the
`
`
`1 Teleflex Innovations S.A.R.L. transferred to Teleflex Medical Devices S.A.R.L.
`all assets and rights, including all intellectual property rights. As a result, Teleflex
`Medical Devices S.A.R.L. is now the owner of U.S. Patent RE45,760. Teleflex is
`preparing and will soon record confirmatory assignment documents with the
`United States Patent & Trademark Office.
`
`
`
`
`2
`
`
`
`District of Minnesota in Vascular Solutions, Inc. v. Boston Scientific Corp., No.
`
`13-cv-01172 (D. Minn., filed May 16, 2013), and (ii) at the PTAB in Boston
`
`Scientific Corp. v. Vascular Solutions, Inc., IPR2014-00762, IPR2014-00763
`
`(P.T.A.B., terminated Aug. 11, 2014).
`
`The Petitioners in this IPR have also filed two other petitions challenging
`
`claims of the ’760 patent, IPR2020-00132 and IPR2020-00134.
`
`3. Lead and Back-Up Counsel
`
`The lead counsel for Patent Owner is:
`
`J. Derek Vandenburgh, Reg. No. 32,179
`Carlson, Caspers, Vandenburgh & Lindquist, P.A.
`Capella Tower, Suite 4200
`225 South Sixth Street
`Minneapolis, MN 55402
`Email: dvandenburgh@carlsoncaspers.com
`Telephone number: (612) 436-9600
`Facsimile number: (612) 436-9605
`
`The back-up counsel for Patent Owner is:
`
`Dennis C. Bremer, Reg. No. 40,528
`Carlson, Caspers, Vandenburgh & Lindquist, P.A.
`Capella Tower, Suite 4200
`225 South Sixth Street
`Minneapolis, MN 55402
`Email: dbremer@carlsoncaspers.com
`Telephone number: (612) 436-9600
`Facsimile number: (612) 436-9605
`
`3
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`4. Service Information
`
`Please address all correspondence to the lead and back-up counsel as shown
`
`
`
`
`above. Patent Owner consents to electronic service by email at the email addresses
`
`provided above.
`
`
`
`Dated: December 3, 2019.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
`
`
`
`/J.Derek Vandenburgh/
`J. Derek Vandenburgh (Lead Counsel)
`Registration No. 32,179
`Carlson, Caspers, Vandenburgh
` & Lindquist, P.A.
`225 South Sixth Street, Suite 4200
`Minneapolis, MN 55402
`Telephone: (612) 436-9600
`Facsimile: (612) 436-9650
`Email:
`DVandenburgh@carlsoncaspers.com
`
`Lead Counsel for Patent Owner
`Teleflex Medical Devices S.A.R.L.
`
`
`4
`
`
`
`CERTIFICATION OF SERVICE
`
`Pursuant to 37 C.F.R. § 42.6(e) and the agreement of the parties, the
`
`
`
`undersigned certifies that on December 3, 2019, a true and correct copy of the
`
`foregoing Mandatory Notices of Patent Owner Teleflex Medical Devices S.A.R.L.
`
`Pursuant to 37 C.F.R. § 42.8 was served via electronic mail upon the following:
`
`Cyrus A. Morton (Reg. No. 44,954)
`Sharon Roberg-Perez (Reg. No. 69,600)
`Christopher A. Pinahs (Reg. No. 76,375)
`Robins Kaplan LLP
`800 LaSalle Avenue, Suite 2800
`Minneapolis, MN 55401
`Phone: 349-8500
`Fax: 612-339-4181
`Email: Cmorton@robinskaplan.com
`Email: Sroberg-perez@robinskaplan.com
`Email: Cpinahs@robinskaplan.com
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`/J.Derek Vandenburgh/
`J. Derek Vandenburgh (Lead Counsel)
`
`
`
`
`
`5
`
`